Evidence map›Paper›PMID 33890324›Full record

ArticleThe International journal of health planning and management2021

Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy.

Antonella Ferro, Paolo Cristofolini, Carlos A Garcia-Etienne, Orazio Caffo, Marco Pellegrini, Carmine Fantò, Salvatore Mussari, Monica Campregher, Silvia Lazzeri, Sara Cantarelli and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The International journal of health planning and management, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Antonella FerroBreast Unit, Ospedale Santa Chiara, Trento, Italy.ORCID https://orcid.org/0000-0003-4109-6769
Paolo CristofoliniBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Carlos A Garcia-EtienneBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Orazio CaffoDepartment of Medical Oncology, Ospedale Santa Chiara, Trento, Italy.
Marco PellegriniBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Carmine FantòBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Salvatore MussariBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Monica CampregherBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Silvia LazzeriBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Sara CantarelliBreast Unit, Ospedale Santa Chiara, Trento, Italy.
Giovanni Maria GuarreraDepartment of Hospital Care, Ospedale Santa Chiara, Trento, Italy.
Ospedale Santa Chiara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Italy was the first western country to be hit by the initial wave of severe adult respiratory syndrome coronavirus 2 pandemic, which has been more widespread in the country's northern regions. Early reports showing that cancer patients are more susceptible to the infection posed a particular challenge that has guided our Breast Unit at Hub Hospital in Trento to making a number of stepwise operational changes. New internal guidelines and treatment selection criteria were drawn up by a virtual multidisciplinary tumour board that took into account the risks and benefits of treatment, and distinguished the patients requiring immediate treatment from those whose treatment could be delayed. A second wave of the pandemic is expected in the autumn as gatherings in closed places increase. We will take advantage of the gained experience and organisational changes implemented during the first wave in order to improve further, and continue to offer breast cancer management and treatment to our vulnerable patient population.

Indexed as

Organizational InnovationAgedBreast NeoplasmsCOVID-19FemaleHumansItalyMedical OncologyRisk Assessmentbreast cancerCOVID-19treatment of breast cancer during COVID-19

Identifiers

PMID33890324
PMCPMC8251150
OpenAlexW3154431507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.